FDC receives ANDA approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution USP Corporates · Oct 4, 2025
FDC shares drop over 3% as Q4 EBITDA falls 4.2% YoY to Rs 54 crore, net profit down 16.4% YoY Stock Market · May 29, 2025
FDC launches two variants of Favipiravir in India for the treatment of COVID-19 Medical · Aug 26, 2020
